Turnstone Biologics is a startup based in the United States, 1 tracked investor.
Turnstone Biologics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Turnstone Biologics is a biopharmaceutical company developing oncolytic virus‑based immunotherapies for cancer; it engineers viral vectors to stimulate anti-tumor immune responses and deliver immunomodulatory payloads. The company focuses on translating these engineered viral therapies into clinical treatments for oncology patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.